1. Home
  2. EOLS

EOLS

Evolus Inc.

as 06-20-2025 3:35pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Founded: 2012 Country:
United States
United States
Employees: N/A City: NEWPORT BEACH
Market Cap: N/A IPO Year: 2018
Target Price: $23.75 AVG Volume (30 days): 1.2M
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.89 EPS Growth: N/A
52 Week Low/High: $8.67 - $17.82 Next Earning Date: 07-30-2025
Revenue: $275,463,000 Revenue Growth: 25.38%
Revenue Growth (this year): 33.39% Revenue Growth (next year): 33.21%

EOLS Daily Stock ML Predictions

Stock Insider Trading Activity of Evolus Inc. (EOLS)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
White Albert G III EOLS Director Jun 9 '25 Buy $9.45 20,000 $189,000.00 50,378
Beaver Sandra EOLS Chief Financial Officer May 13 '25 Sell $10.02 6,494 $65,069.88 167,089
MOATAZEDI DAVID EOLS See Remarks May 12 '25 Sell $9.87 15,787 $155,756.12 492,832
Avelar Rui EOLS See Remarks May 12 '25 Sell $9.87 3,385 $33,396.75 359,082
MOATAZEDI DAVID EOLS See Remarks Mar 27 '25 Sell $12.40 6,251 $77,512.40 492,832

Share on Social Networks: